Triplet lifetimes, solvent and intramolecular capture of isoxazolones

150 OXFORD ST, PO BOX 1139, COLLINGWOOD, AUSTRALIA, VICTORIA, 306

Blockchain technology the identity management and authentication service disruptor:A survey

The Internet today lacks an identity protocol for identifying people and organizations. As a result, service providers needed to build and maintain their own databases of user information. This solution is costly to the service providers, inefficient as much of the information is duplicated across different providers, difficult to secure as evidenced by recent large-scale personal data breaches around the world, and cumbersome to the users who need to remember different sets of credentials for different services. Furthermore, personal information could be collected for data mining, profiling and exploitation without users' knowledge or consent. The ideal solution would be self-sovereign identity, a new form of identity management that is owned and controlled entirely by each individual user. This solution would include the individual's consolidated digital identity as well as their set of verified attributes that have been cryptographically signed by various trusted issuers. The individual provides proof of identity and membership by sharing relevant parts of their identity with the service providers. Consent for access may also be revoked hence giving the individual full control over its own data. This survey critically investigates different blockchain based identity management and authentication frameworks. A summary of the state-of-the-art blockchain based identity management and authentication solutions from year 2014 to 2018 is presented. The paper concludes with the open issues, main challenges and directions highlighted for future work in this area. In a nutshell, the discovery of this new mechanism disrupted the existing identity management and authentication solutions and by providing a more promising secure platform

SARS-CoV-2 vaccination modelling for safe surgery to save lives: Data from an international prospective cohort study

Background: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18-49, 50-69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results: NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion: As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

Background: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18-49, 50-69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results: NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion: As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population